Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 3,236

Document Document Title
WO/1997/021432A1
The therapeutical use of bicyclic derivatives and pharmaceutically acceptable salts thereof having general formula (I), wherein each of X1, X2, X3 and X4 is independently a carbon atom or a nitrogen atom, with n being 0 or 1; A is select...  
WO/1997/020805A1
Indane dimer compounds of general formula 5, 6 or 9 and their pharmaceutical use, particularly to achieve smooth muscle relaxing activity and/or mast cell stabilising activity and/or antiinflammatory activity are described, wherein in fo...  
WO/1997/020806A1
Indane compounds of general formulas (7) and (8) and their pharmaceutical use particularly to achieve smooth muscle relaxing activity and/or mast cell stabilising activity and/or anti-inflammatory activity as described, wherein in formul...  
WO/1997/020802A1
Indame dimer compounds and their pharmaceutical use particularly to achieve smooth muscle relaxing activity and/or mast cell stabilising activity and/or anti-inflammatory activity are described.  
WO/1997/019675A2
Cationic lipids, having a derivated quaternary ammonium head group, that provide improved cell targeting ability and enhanced transfective efficacy for negatively charged macromolecules. The lipids comprise a linker having functional gro...  
WO/1997/016544A1
A chemical linking agent formed of a di- or higher functional photoactivatable compound and providing at least one group that is charged under the conditions of use in order to provide improved water solubility. The linking agent further...  
WO/1997/016406A1
A compound of the formula (I): A-L-D where A is a moiety which absorbs radiation and enters an excited state in which it accepts an electron; L is a linking group which tethers an electron acceptor moiety A to the electron donor moiety D...  
WO/1997/007101A1
A method of treating neoplastic disease which comprises the steps of: (a) administering to a patient in need of such treatment an effective amount of a radiation-activated cytotoxin prodrug (RACP) which has low toxicity, which can be red...  
WO/1997/006200A1
Controlled molecular weight imide oligomers and co-oligomers containing pendent phenylethynyl groups (PEPIs) and endcapped with nonreactive or phenylethynyl groups have been prepared by the cyclodehydration of the precursor amide acid ol...  
WO/1997/006135A1
A process for producing carbamoylmethylurea derivatives represented by general formula (I), characterized by reacting a compound represented by general formula (II) with a compound represented by general formula (III).  
WO/1996/038150A1
The present invention relates to novel 4.4-(disubstituted)cyclohexan-1-ols monomers and related compounds, pharmaceutical compositions containing these compounds, and their use in treating allergic and inflammatory diseases and for inhib...  
WO/1996/032370A1
4-Amino-5-oxy-2,6,6-trimethyl-2-cycloheptene compounds represented by general formula (I), pharmacologically acceptable salts thereof, or solvates of these wherein R1 and R2 independently represent each hydrogen, optionally substituted a...  
WO/1996/021354A1
Pesticidal as a pesticide against whitefly, Lepidoptera and certain fungi is provided of compound of general formula (I) or a salt thereof is provided, in which n represents an integer from 0 to 4; m represents an integer 0 or 1; each R ...  
WO/1996/020795A1
The invention concerns NCO-terminated vinyl telomers which are particularly suitable for use as surface-modifying agents and as coating materials, but also in the production of polymerizable compounds or block copolymers which react to g...  
WO/1996/020964A1
The invention concerns a cross-linked polymer built up from a polymerization product of a highly unsaturated polymer (a) and a polysiloxane (b) with terminal or pendentive hydrosilane groups in such a way that numerous unsaturated carbon...  
WO/1996/021167A1
The invention concerns cross-linked polymers which are the polymerization products of a polymerizable mixture containing the following components: a) a macromer of formula (C) in which Macro is an m-valent macromer group from which m of ...  
WO/1996/019995A1
This invention relates to derivatives of 4,4-(disubstituted)cyclohexan-1-ones and related compounds which are useful for treating allergic and inflammatory diseases.  
WO/1996/019988A1
The present invention relates to novel 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds, pharmaceutical compositions containing these compounds, and their use in treating allergic and inflammatory diseases and for inhib...  
WO/1996/020158A1
This invention relates to derivatives of 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds which are useful for treating allergic and inflammatory diseases.  
WO1996012697A3  
WO/1996/014300A1
The compounds of formula (I), wherein R1 is hydrogen, C1-10 straight or branched chain alkyl, C3-10 cyclic or bicyclic alkyl, alkanoyl of 2 to 7 carbon atoms, alkylsulfonyl of 1 to 7 carbon atoms, aroyl of 7 to 12 carbon atoms, arylalken...  
WO/1996/012697A2
The present invention features compounds of general formulae a), b), c), able to modulate one or more activities of an inorganic ion receptor and methods for treating diseases or disorders by modulating inorganic ion receptor activity. P...  
WO/1996/011894A1
Proposed is a process for separating enantiomers from a racemic mixture by countercurrent extraction using at least two substances, one of them a liquid in which the racemic mixture to be separated is present, the other containing a chir...  
WO/1996/009807A1
The invention concerns the use of 2-hydroxy-1-ethanone derivatives for dyeing keratin-containing fibres, in particular human hair.  
WO/1996/009297A1
Novel compounds, compositions and methods effective for the prevention and treatment of mast-cell mediated inflammatory disorders are described. The compounds, compositions and methods are effective for the prevention and treatment of in...  
WO/1996/006068A1
A benzene compound represented by general formula (I) (wherein each symbol is as defined in the specification), an optical isomer or salt thereof, a medicinal composition containing the same, and an immunosuppressant containing the same ...  
WO/1996/004895A1
The present invention provides the new use in the treatment of amyloidosis with the anthracyclinone of formula (A) wherein R1, R2, R3, R4 and R5, are appropriate substituents. Some compounds of formula (A) are novel. Processes for their ...  
WO/1996/004230A1
Terpene-quinone with antitumor activity defined from a cyclocondensation reaction of Diels-Alder, used to obtain families or series of said compounds having a new structure and presenting a cytotoxic activity to cellular cultures P-388, ...  
WO/1996/003476A1
The present invention is directed to stable liquid-crystalline glasses which have a high Tg and are readily orientable. Such glasses are suitable for use in optical applications. The glasses according to the invention are obtained by rea...  
WO/1996/003364A1
A benzoylethylene derivative represented by general formula (I) and a salt thereof wherein R1 to R5 represent each hydrogen, -OR9 (R9 being hydrogen, C1-C5 alkyl, etc.), etc.; R6 represents hydrogen, C1-C5 alkyl, etc.; R7 represents hydr...  
WO/1996/000725A1
This invention relates to novel 4-(3,4-dioxocyclobuten-1-yl)chromenes and dihydronaphthalenones and 3-(3,4-dioxocyclobuten-1-yl)indenes and salts thereof having smooth muscle relaxing activity, to their use in the treatment of hypertensi...  
WO/1995/033455A1
Novel meta substituted arylalkylamine compounds are disclosed. These compounds can be administered as small molecule drugs to treat diseases or conditions associated with insufficient serotonin mediated nerve transmission (e.g. depressio...  
WO/1995/030641A1
New compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities, of the general formula: A-X1-NO2 or their salts, wherein: A is R(COXu)t, wherein t is zero or 1 and u is zero or 1; and X is O, NH o...  
WO/1995/030646A1
The present invention relates to compounds which are useful as sunscreens. The compounds persists on the skin for much longer than conventional sunscreens because they comprise a Michael acceptor linked directly or indirectly to a chromo...  
WO/1995/029167A1
The invention relates to novel substituted cyclopropylcarbonyl-phenylaminosulphonyl ureas of formula (I) in which the constituents R1, R2, R3 and R4 have the meanings given in the description and R5 is optionally halogen or C1-C4 alkyl-s...  
WO/1995/026327A1
The use of a compound of formula (I), wherein X represents O, S, C=O or a bond; p and q independently represent 0-4; R1 and R2 each independently represent hydrogen, C1-6alkyl, C3-6cycloalkyl or C3-6cycloalkylC1-4alkyl; n is 1, 2, 3 or 4...  
WO/1995/022546A1
Therapeutic compounds with at least one carboxylic, acid, ester or amide-substituted moiety have the formula: TERMINAL MOIETY-(R)j. In the formula, j is an integer from one to three, the terminal moiety is an aliphatic chemical moiety or...  
WO/1995/022520A1
A compound of structure (I), wherein, when R8 = H: R1 = alkyl, cycloalkyl, arylalkyl, aryl; R2 = cycloalkyl, aryl, C3-C10 alkyl; X, Y = O, S(O)n, NH; Z = CH2OH, NHSO2R3, CHO, CO2R3, CONHR4R5, CN, COR6, H, halo, NHCN, NHCONR4R5, CONR4OR5,...  
WO/1995/021813A1
This invention concerns compounds of generic formula (I) or a pharmaceutically acceptable salt thereof, where the dotted line represents an optional bond, one of R1 and R5 represents hydrogen, C1-C6 alkyl, C7-C16 aralkyl, -(CHR6)nCHR7CN,...  
WO/1995/018092A1
An amino ketone derivative represented by general formula (I), a physiologically acceptable salt thereof, a process for producing the same, and a central muscle relaxant and a remedy for frequent urination each containing the derivative ...  
WO/1995/011224A1
Intermediates and processes are disclosed which are useful for the preparation of a substantially pure compound of formula (3), wherein R6 and R7 are each hydrogen or R6 and R7 are independently selected from (i), wherein Ra and Rb are i...  
WO/1995/011221A1
The present invention features molecules with general structure (I) or (II) which can modulate on or activities of an inorganic ion receptor. Preferably, the molecule can mimic or block the effect of extracellular Ca2+ on a calcium recep...  
WO/1995/010545A1
The present invention relates to a novel process for the production of fuel and lubricant additives useful as dispersants and multifunctional viscosity modifiers wherein a dihydroxyaromatic compound is alkylated with an olefinic polymer ...  
WO/1995/009149A1
A compound having structural formula (I), where R1 and R2 are independently hydrogen or hydroxyl, R2 and R3 are independently oxo or hydrogen, one of R5 and R6 is A-B and the other is hydrogen, hydroxyl, or a group A, wherein the or each...  
WO/1995/009379A1
The invention is in the field of retardation layers comprising high-molecular weight liquid-crystalline material for liquid-crystalline displays. The invention is directed to a retardation layer for a liquid-crystalline display comprisin...  
WO/1995/007885A1
Compounds of formula (I), wherein R is a hydrogen atom or an OY group; R1 is a hydrogen atom or an OY' group; R2 is a hydrogen atom or an OY'' group; provided that at least one among R, R1 and R2 is hydrogen but R, R1 and R2 are not cont...  
WO/1995/005805A1
The present invention relates to a process for providing a stable crystallinic form to a fine-grained substance or a substance mixture, which can be produced, stored and used while maintaining the aerodynamic properties required for inha...  
WO/1995/004713A1
Compounds and their pharmaceutically acceptable salts suitable for treating central nervous system disorders associated with the dopamine D3 receptor activity of formula (I), wherein R1 and R2 are independently chosen from hydrogen, C1-C...  
WO/1995/003791A1
This application discloses a method of inhibiting degradation of the antidepressant bupropion hydrochloride in a solid pharmaceutical formulation, so that the pharmaceutical formulation will maintain at least 80 % of its initial bupropio...  
WO/1995/003267A1
The present invention relates to 1,2-benzoquinones; methods of preparation of 1,2-benzoquinones that include preparation of 4,5-substituted- 1,2-benzoquinones in a one-pot reaction; and methods of treatment and pharmaceutical composition...  

Matches 551 - 600 out of 3,236